Orthopedic Splints Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Orthopedic Splints Market is Segmented by Product (Fiberglass Splints, Plaster Splints, and More), Material (Fiberglass, Plaster of Paris, and More), Application (Lower Extremity [Hip, Knee, and More], Upper Extremity, and Spinal), End-User (Hospitals and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The Market and Forecasts are Provided in Terms of Value (USD).

Orthopedic Splints Market Size and Share

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Compare market size and growth of Orthopedic Splints Market with other markets in Healthcare Industry

Orthopedic Splints Market Analysis by Mordor Intelligence

The orthopedic splints market size reached USD 1.69 billion in 2025 and is forecast to climb to USD 2.67 billion by 2030, reflecting a solid 9.58% CAGR over the period. Demand expands as populations age, sports participation rises, and care delivery shifts toward outpatient settings. Material advances, notably the move from plaster to lighter composites and 3-D printed forms, shorten application times and improve patient comfort, encouraging faster provider uptake. Regulatory agencies now pilot lifecycle-based review pathways that reward clinically validated innovation while reimbursement schedules push providers to favor cost-efficient, outcomes-oriented products. Together, these dynamics keep pricing disciplined and stimulate continual product refresh cycles, sustaining momentum in the orthopedic splints market.

Key Report Takeaways

  • By product type, fiberglass captured 45.42% of orthopedic splints market share in 2024, while 3-D printed custom splints are positioned for a 10.34% CAGR through 2030.
  • By material, fiberglass held 44.43% share of the orthopedic splints market size in 2024; thermoplastics are on track for a 10.22% CAGR to 2030.  
  • By application, lower extremity splints accounted for 51.23% of the orthopedic splints market size in 2024, whereas spinal applications are projected to grow at 10.36% CAGR through 2030.  
  • By end user, hospitals led with 48.91% revenue share in 2024, and orthopedic clinics are expected to post the fastest CAGR of 10.43% to 2030.  
  • By geography, North America dominated with 41.44% share in 2024, while Asia-Pacific is anticipated to advance at 10.59% CAGR during the forecast window.  

Segment Analysis

By Product: Momentum Shifts Toward Custom Printing

Fiberglass splints held 45.42% of the orthopedic splints market in 2024, anchored by their low cost, broad clinical familiarity, and established reimbursement pathways. Providers value fiberglass for predictable rigidity and quick setting, making it a go-to in trauma bays. Yet 3-D printed custom splints, expanding at 10.34% CAGR, are redrawing competitive boundaries. Randomized trials document lower pain, improved satisfaction, and fewer pressure sores when additive-manufactured designs replace bulkier polymers. Hospitals experimenting with in-house printers reduce turnaround from multi-day outsource cycles to same-day fittings, raising patient throughput while trimming inventory risk.

Growth in 3-D printing ripples through accessory markets such as scanning devices, design software, and consumable filaments, creating new revenue chains for suppliers that pivot early. Hybrid items mixing printed frameworks with traditional wrap materials cater to price-sensitive buyers yet preserve customization benefits. Plaster casts, although declining, retain a foothold in austere settings where technology budgets remain tight. Overall, diversified offerings allow manufacturers to segment by acuity and price point, supporting sustained value capture across the orthopedic splints market.

Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By Material: Thermoplastics Target Comfort and Sustainability

Fiberglass accounted for 44.43% of the orthopedic splints market in 2024, but thermoplastics are expanding fastest at 10.22% CAGR through 2030. Remoldable at moderate heat, thermoplastic sheets let clinicians fine-tune alignment during follow-up visits, curbing revision rates. Breathability and waterproof attributes also translate into higher patient compliance, a key driver in pediatric and sports cohorts. Regulatory bodies now encourage greener healthcare, prompting providers to explore biodegradable polymer alternatives that degrade without micro-plastic residue.

Carbon-fiber composites occupy the premium tier, validated by dedicated reimbursement codes that recognize their tensile strength-to-weight advantage for ankle-foot immobilization. Unit prices exceed mainstream fiberglass by a wide margin, yet elite athletes and postoperative cases justify the premium. Plaster of Paris persists where moldability and ultra-low cost dominate buying criteria, particularly in low-resource markets. As sustainability agendas intensify, suppliers investing in recyclable resin technologies may seize an early branding advantage in the orthopedic splints market.

By Application: Spinal Care Picks Up Pace

Lower extremity injuries drove 51.23% of the orthopedic splints market size in 2024, reflecting high ankle and knee trauma totals from sports and occupational mishaps. Emergency departments routinely stock multiple form factors to address sprains, fractures, and ligament tears. However, spinal splinting is set to grow fastest at 10.36% CAGR as vertebral fracture incidence rises with aging demographics. Non-operative protocols increasingly favor thoracolumbar orthoses to stabilize compression fractures, limiting kyphotic progression and mitigating postoperative risk.

Upper extremity splits maintain steady cadence, capturing repeat business from manual labor and contact-sport populations. Hand-based devices attract interest from industrial employers seeking rapid return-to-work solutions. Neck and shoulder splints dovetail with the surge in office-related musculoskeletal complaints, broadening outpatient penetration. Hip stabilization remains a specialized niche, yet longer life expectancy plus active senior lifestyles create scope for targeted innovations, further lifting overall momentum in the orthopedic splints market.

Orthopedic Splints Market: Market Share by Application
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Note: Segment shares of all individual segments available upon report purchase

By End User: Clinics Rise, Hospitals Hold Ground

Hospitals retained 48.91% revenue share in 2024, fueled by 24-hour trauma cover and bundled care pathways that funnel acute fractures into emergency bays. Nonetheless, orthopedic clinics will post the highest 10.43% CAGR through 2030 as payers nudge procedures toward lower-cost sites and surgeons seek ownership stakes in ambulatory facilities. Specialized clinic settings streamline patient flow, support rapid 3-D scanning, and provide tailored rehabilitation services under one roof.

Home healthcare adoption accelerates behind tele-rehab platforms, enabling clinicians to monitor fit and compliance remotely. Equivalence studies in joint arthroplasty rehabilitation suggest similar functional scores between supervised home programs and in-person visits, encouraging insurers to reimburse remote monitoring devices stapled to splints. Sports medicine centers and occupational health units round out demand, leveraging premium splints to speed up athlete or worker reintegration. This diversified site-of-care mix cushions suppliers against policy swings and underscores the growing complexity of the orthopedic splints market.

Geography Analysis

North America commanded 41.44% share of the orthopedic splints market in 2024 thanks to advanced trauma infrastructure, high elective procedure rates, and early adoption of material and manufacturing innovation. Provider consolidation has improved purchasing power, prompting suppliers to bundle value-added services such as digitized inventory tracking and in-service training. Regulatory pilots like the Total Product Life Cycle Advisory Program for orthopedic devices aim to shorten innovation cycles but simultaneously push manufacturers to supply post-market safety data, raising compliance costs.

Asia-Pacific represents the fastest expansion corridor with a 10.59% CAGR projected to 2030. Urbanization, expanding insurance coverage, and increasing disposable income translate into higher musculoskeletal injury treatment rates. Governments in China, India, and South Korea now subsidize domestic additive-manufacturing lines, lessening import dependence and fostering region-specific product variants tailored to local anthropometry. Large patient pools allow quick scaling of production volumes, reinforcing supplier interest in localized joint ventures. Rising sports participation and traffic-related fractures further enlarge the addressable base for the orthopedic splints market.

Europe maintains moderate growth underpinned by aging demographics and universal health systems that guarantee device reimbursement. Environmental stewardship directives compel hospitals to set procurement targets for recyclable or biodegradable materials, stimulating supplier investment in green formulations. Middle East and Africa markets expand from a small base, with gulf states importing premium devices for expatriate workforces and domestic populations alike. South America shows momentum in Brazil and Argentina, where public-private healthcare partnerships improve device availability and clinician training. Collectively, geographical breadth cushions the orthopedic splints market against single-region downturns and underwrites sustained global revenues.

Orthopedic Splints Market CAGR (%), Growth Rate by Region
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.

Competitive Landscape

The orthopedic splints market features moderate fragmentation; no single vendor controls a double-digit global share across every subcategory. Multinationals such as Zimmer Biomet, Ossur, and Stryker focus on high-margin 3-D printed and carbon-fiber offerings, leveraging R-and-D scale and regulatory experience to secure early approvals. Mid-tier specialists differentiate through niche expertise; OrthoPediatrics, for instance, targets pediatric anatomies and has deepened this focus via the acquisition of Boston Orthotics & Prosthetics. Local players in China and India compete on cost and increasingly on design customization, using domestic manufacturing incentives to accelerate engineering cycles.

Strategic alliances blend digital, material, and clinical competencies. Software firms supply artificial-intelligence-driven design algorithms that shorten print-to-patient time, while material scientists collaborate on bioresorbable composites. Venture-funded start-ups pilot subscription models that ship central-lab-printed splints to remote clinics, bypassing capital investment in printers. Intellectual-property portfolios concentrate around lattice structures optimized for strength-to-weight ratio, spurring occasional infringement disputes. Despite competitive churn, switching barriers remain low, keeping buyer leverage high and reinforcing continuous innovation as the path to margin defense in the orthopedic splints market.

Regulatory shifts also shape rivalry. Expanded real-world evidence demands favor companies capable of integrating sensor-enabled splints that feed usage data to payers, supporting reimbursement renewals. Conversely, prior authorization rules for certain bracing categories slow uptake of higher-priced devices, favoring vendors with strong payer-relation teams. Sustainability mandates in Europe and select US health networks reward suppliers able to certify cradle-to-grave environmental impact reductions, adding a new vector of competition beyond clinical efficacy and cost.

Orthopedic Splints Industry Leaders

  1. DeRoyal Industries, Inc.

  2. Zimmer Biomet

  3. Stryker

  4. Dynatronics Corporation (Bird & Cronin)

  5. Solventum

  6. *Disclaimer: Major Players sorted in no particular order
Orthopedic Splint Market Concentration
Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0.
Need More Details on Market Players and Competitors?
Download PDF

Recent Industry Developments

  • January 2025: Dimension Ortho announced a strategic partnership with Rothman Orthopaedics. Through this collaboration, Rothman will implement Dimension Ortho's breakthrough platform for personalized bracing and fracture care across its clinical sites, setting a new standard for patient care.
  • May 2024: Create it REAL, a Danish 3-D printing R&D center specializing in orthopedics, reported plans to launch a digital ordering platform to streamline custom splint production services.
  • April 2024: Brace Direct opened a new distribution center aimed at reducing delivery times for its orthopedic immobilization portfolio.

Table of Contents for Orthopedic Splints Industry Report

1. Introduction

  • 1.1 Study Assumptions & Market Definition
  • 1.2 Scope of the Study

2. Research Methodology

3. Executive Summary

4. Market Landscape

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Musculoskeletal Disorder Burden
    • 4.2.2 Growing Geriatric Population
    • 4.2.3 Increasing Sports & Traffic?Related Fractures
    • 4.2.4 Material Innovations Including Water-Proof and Lightweight Composites
    • 4.2.5 Rapid Adoption Of 3-D Printed Custom Splints
    • 4.2.6 Home-Based & OTC Splinting Via E-Commerce and Tele-Rehab
  • 4.3 Market Restraints
    • 4.3.1 Negligence Toward Minor Injuries
    • 4.3.2 Availability Of Functional Braces & Walking Boots
    • 4.3.3 Reimbursement Gaps for OTC Splints in Ems
    • 4.3.4 Environmental Disposal Concerns for Fiberglass/Plastics
  • 4.4 Regulatory Landscape
  • 4.5 Technological Outlook
  • 4.6 Porters Five Forces Analysis
    • 4.6.1 Threat of New Entrants
    • 4.6.2 Bargaining Power of Buyers
    • 4.6.3 Bargaining Power of Suppliers
    • 4.6.4 Threat of Substitutes
    • 4.6.5 Competitive Rivalry

5. Market Size & Growth Forecasts (Value, USD)

  • 5.1 By Product
    • 5.1.1 Fiberglass Splints
    • 5.1.2 Plaster Splints
    • 5.1.3 Thermoplastic Splints
    • 5.1.4 3-D Printed Custom Splints
    • 5.1.5 Splinting Tools & Accessories
    • 5.1.6 Other Products
  • 5.2 By Material
    • 5.2.1 Fiberglass
    • 5.2.2 Plaster of Paris
    • 5.2.3 Thermoplastics
    • 5.2.4 Carbon-Fiber Composites
    • 5.2.5 Others
  • 5.3 By Application
    • 5.3.1 Lower Extremity
    • 5.3.1.1 Ankle & Foot
    • 5.3.1.2 Hip
    • 5.3.1.3 Knee
    • 5.3.2 Upper Extremity
    • 5.3.2.1 Elbow
    • 5.3.2.2 Hand & Wrist
    • 5.3.2.3 Neck
    • 5.3.2.4 Shoulder
    • 5.3.3 Spinal
  • 5.4 By End-user
    • 5.4.1 Hospitals
    • 5.4.2 Ambulatory Surgical Centers
    • 5.4.3 Orthopedic Clinics
    • 5.4.4 Others
  • 5.5 By Geography
    • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
    • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 South Korea
    • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
    • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6. Competitive Landscape

  • 6.1 Market Concentration
  • 6.2 Market Share Analysis
  • 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials, Strategic Info, Market Rank/Share, Products & Services, Recent Developments)
    • 6.3.1 Solventum
    • 6.3.2 Essity (BSN Medical)
    • 6.3.3 Zimmer Biomet
    • 6.3.4 Stryker Corporation
    • 6.3.5 Orthofix Medical Inc.
    • 6.3.6 Otto Bock Healthcare GmbH
    • 6.3.7 DeRoyal Industries Inc.
    • 6.3.8 Medi GmbH & Co. KG
    • 6.3.9 Dynatronics (Bird & Cronin)
    • 6.3.10 Patterson Medical Holdings
    • 6.3.11 Tynor Orthotics
    • 6.3.12 Plasti Surge Industries
    • 6.3.13 Ossur hf
    • 6.3.14 Breg Inc.
    • 6.3.15 Bauerfeind AG
    • 6.3.16 Enovis (DJO Global)
    • 6.3.17 DePuy Synthes
    • 6.3.18 Smith & Nephew plc
    • 6.3.19 Alimed Inc.
    • 6.3.20 Sam Medical Products

7. Market Opportunities & Future Outlook

  • 7.1 White-space & Unmet-Need Assessment
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Global Orthopedic Splints Market Report Scope

As per the report's scope, splints are medical devices used to immobilize damaged or injured bones to enhance the healing rate. The splints are considered non-circumferential devices. A splint can be used for certain fractures, soft tissue sprains or tendon injuries, or injuries awaiting orthopedic treatment. The Orthopedic Splint Market is Segmented by Product (Fiberglass Splints, Plaster Splints, Splinting Tools and Accessories, and Other Products), Application (Lower Extremity, Upper Extremity, and Spinal), End-user (Hospitals, Outpatient Centers, and Other End-users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD million) for the above segments.

By Product Fiberglass Splints
Plaster Splints
Thermoplastic Splints
3-D Printed Custom Splints
Splinting Tools & Accessories
Other Products
By Material Fiberglass
Plaster of Paris
Thermoplastics
Carbon-Fiber Composites
Others
By Application Lower Extremity Ankle & Foot
Hip
Knee
Upper Extremity Elbow
Hand & Wrist
Neck
Shoulder
Spinal
By End-user Hospitals
Ambulatory Surgical Centers
Orthopedic Clinics
Others
By Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
By Product
Fiberglass Splints
Plaster Splints
Thermoplastic Splints
3-D Printed Custom Splints
Splinting Tools & Accessories
Other Products
By Material
Fiberglass
Plaster of Paris
Thermoplastics
Carbon-Fiber Composites
Others
By Application
Lower Extremity Ankle & Foot
Hip
Knee
Upper Extremity Elbow
Hand & Wrist
Neck
Shoulder
Spinal
By End-user
Hospitals
Ambulatory Surgical Centers
Orthopedic Clinics
Others
By Geography
North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Key Questions Answered in the Report

What is the current value of the orthopedic splints market?

The orthopedic splints market size stood at USD 1.69 billion in 2025 and is projected to reach USD 2.67 billion by 2030.

Which product type dominates global sales?

Fiberglass splints led the market with 45.42% share in 2024, benefiting from low cost and broad clinical familiarity.

Which region is expanding fastest?

Asia-Pacific is forecast to grow at a 10.59% CAGR through 2030 as insurance coverage broadens and injury incidence climbs.

How are 3-D printed splints influencing growth?

3-D printed custom splints deliver superior patient comfort and shorter lead times, driving a 10.34% CAGR and reshaping competitive dynamics.

Why are thermoplastic materials gaining traction?

Thermoplastics allow remolding during follow-up, improve breathability, and support waterproof designs, factors contributing to their 10.22% CAGR.

What restrains market expansion despite strong demand?

Substitution by functional braces and persistent care-access gaps for minor injuries limit near-term adoption in certain patient groups.

Page last updated on: July 1, 2025

Orthopedic Splints Market Report Snapshots